Exploratory Study of FYU-981 for Hyperuricemia With or Without Gout (Phase II (IIa) Study)

Next Previous
Trial Profile

Exploratory Study of FYU-981 for Hyperuricemia With or Without Gout (Phase II (IIa) Study)

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Jan 2015

At a glance

  • Drugs FYU-981 (Primary)
  • Indications Gout; Hyperuricaemia
  • Focus Therapeutic Use
  • Sponsors Fuji Yakuhin

    • Most Recent Events

    • 30 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top